Therefore, large and carefully designed case–control studies need to be performed to provide the best evidence for the possible associations between the XRCC1 R194W and R280H polymorphisms and bladder cancer risk among Asian populations and African populations. Here, XRCC1 is linked to urinary bladder cancer.